Severe Aortic Stenosis: Stratifying Patients for Lifetime Management

In this satellite symposium, 'Severe Aortic Stenosis: Stratifying Patients for Lifetime Management' hear from leading faculty as they consider when to use a surgery or TAVI-first approach, summarise clinical evidence to date and assess possible management scenarios by way of clinical cases.

This symposium is part of Transcatheter Interventions Online 2022, a world-class virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.


Target Audience

This programme is intended to educate:

  • Interventional cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional cardiology nurses


Learning Objectives

The symposium, ‘Severe Aortic Stenosis: Stratifying Patients for Lifetime Management’, endeavours to best address the following learning objectives:

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient


In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

This programme is supported by unrestricted educational grants from Edwards Lifesciences. The scientific programme has not been influenced in any way by the sponsors.



Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

The session of ‘Severe Aortic Stenosis: Stratifying Patients for Lifetime Management’ is accredited by the European Board for Accreditation in Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. 



There is no fee for taking part in this online learning activity.

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Course summary
Available credit: 
  • 1.00 European Board for Accreditation in Cardiology (EBAC)
Course opens: 
Course expires: 

Session 1 - Forward Planning in Severe AS
In the opening chapter, Dr David Wood begins the symposium by providing a short outline on the updated guidelines, the considerations for long term management including age patient preferences. Dr David Wood closes his with hemoynamics and durability by providing an oversight into the process physicians are following with COMPLETE TAVR and DISCORDANCE TAVR.

Session 2 - SAVR vs TAVI in Younger Patients - What do the Clinical Data tell us?
Dr Victoria Delgado dives into the data and clinical data physicians have, and touches on the history and the rise of TAVI with low-risk and high-risk patients.

Session 3 - SAVR or TAVI First in Younger Candidates: A Question of Hypotheticals?
In the final chapter, Dr Rebecca Hahn presents a provocative patient case study. The chapter concludes with Dr Hahn asking the faculty important questions, and provides a series of scenarios for the panel to discuss.


Session Chair
Prof Thomas Modine, UMCV, hopital Haut Leveque, CHU de Bordeaux 

Presenters and Panel
Dr David Wood, Vancouver General Hospital, Canada
Dr Victoria Delgado, Germans Trias i Pujol Hospital, Barcelona
Dr Rebecca Hahn, Columbia University Irving Medical Center, New York

Available Credit

  • 1.00 European Board for Accreditation in Cardiology (EBAC)
Please login or register to take this course.